Pregnancy and glomerular disease: A systematic review of the literature with management guidelines

Clinical Journal of the American Society of Nephrology

Volumn 12, Issue 11, 2017, Pages 1862-1872

  Blom, Kimberly ^a   Odutayo, Ayodele ^a   Bramham, Kate ^b   Hladunewich, Michelle A ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Glomerular disease; Glomerulonephritis; Pregnancy; Systematic review

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CREATININE; CYCLOPHOSPHAMIDE; LEUPRORELIN; MYCOPHENOLATE MOFETIL; PREDNISONE; RITUXIMAB;

BIRTH WEIGHT; CHRONIC KIDNEY FAILURE; CONTRACEPTION; ESTIMATED GLOMERULAR FILTRATION RATE; FERTILITY; GESTATIONAL AGE; GLOMERULOPATHY; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; LIVE BIRTH; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; META ANALYSIS (TOPIC); PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL CARE; PREPREGNANCY CARE; PROTEINURIA; PUERPERIUM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTEMATIC REVIEW; COMPLICATION; FEMALE; GLOMERULONEPHRITIS; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATION;

FEMALE; GLOMERULONEPHRITIS; HUMANS; LUPUS NEPHRITIS; POSTNATAL CARE; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; RENAL INSUFFICIENCY, CHRONIC;

EID: 85033372329     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00130117     Document Type: Review

References (93)

1. Piccoli GB, Cabiddu G, Attini R, Vigotti FN, Maxia S, Lepori N, Tuveri M, Massidda M, Marchi C, Mura S, Coscia A, Biolcati M, Gaglioti P, Nichelatti M, Pibiri L, Chessa G, Pani A, Todros T: Risk of adverse pregnancy outcomes in women with CKD. J AmSoc Nephrol 26: 2011–2022, 2015
2. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD: A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 5: 2060–2068, 2010
3. Surian M, Imbasciati E, Cosci P, Banfi G, Barbiano di Belgiojoso G, Brancaccio D, Minetti L, Ponticelli C: Glomerular disease and pregnancy. A study of 123 pregnancies in patients with primary and secondary glomerular diseases. Nephron 36: 101–105, 1984
4. Barceló P, López-Lillo J, Cabero L, Del Río G: Successful pregnancy in primary glomerular disease. Kidney Int 30: 914–919, 1986
5. Jungers P, Forget D, Henry-Amar M, Albouze G, Fournier P, Vischer U, Droz D, Noël LH, Grunfeld JP: Chronic kidney disease and pregnancy. Adv Nephrol Necker Hosp 15: 103–141, 1986
6. Kincaid-Smith P, Fairley KF: Renal disease in pregnancy. Three controversial areas: Mesangial IgA nephropathy, focal glomerular sclerosis (focal and segmental hyalinosis and sclerosis), and reflux nephropathy. Am J Kidney Dis 9: 328–333, 1987
7. Packham DK, North RA, Fairley KF, Whitworth JA, Kincaid-Smith P: IgA glomerulonephritis and pregnancy. Clin Nephrol 30: 15–21, 1988
8. Nagai Y, Waschizawa Y, Suzuki T, Fushimi T, Hirata K, Kawamura S, Schiina K, Tanaka M, Maeda M: Influence of gestation on renal function in gravida with IgA nephropathy. Nihon Jinzo Gakkai Shi 31: 635–641, 1989
9. Abe S: Pregnancy in IgA nephropathy. Kidney Int 40: 1098–1102, 1991
10. Limardo M, Imbasciati E, Ravani P, Surian M, Torres D, Gregorini G, Magistroni R, Casellato D, Gammaro L, Pozzi C; Renee Gravidanza Collaborative Group of the Italian Society of Nephrology: Pregnancy and progression of IgA nephropathy: Results of an Italian multicenter study. Am J Kidney Dis 56: 506–512, 2010
11. Shimizu A, Takei T, Moriyama T, Itabashi M, Uchida K, Nitta K: Effect of kidney disease stage on pregnancy and delivery outcomes among patients with immunoglobulin A nephropathy. Am J Nephrol 32: 456–461, 2010
12. Waness A, Al Sayyari A, Salih SB, Al Shohaib S: Increased risk of hypertension, protein uria and preeclampsia in pregnant Saudi females with IgA nephropathy. Hypertens Pregnancy 29: 385–389, 2010
13. Liu Y, Ma X, Lv J, Shi S, Liu L, Chen Y, Zhang H: Risk factors for pregnancy outcomes in patients with IgA nephropathy: A matched cohort study. Am J Kidney Dis 64: 730–736, 2014
14. Packham D, Whitworth JA, Fairley KF, Kincaid-Smith P: Histological features of IgA glomerulonephritis as predictors of pregnancy outcome. Clin Nephrol 30: 22–26, 1988
15. Packham DK, North RA, Fairley KF, Ihle BU, Whitworth JA, Kincaid-Smith P: Pregnancy in women with primary focal and segmental hyalinosis and sclerosis. Clin Nephrol 29: 185–192, 1988
16. Abe S, Amagasaki Y, Konishi K, Kato E, Sakaguchi H, Iyori S: The influence of antecedent renal disease on pregnancy. Am J Obstet Gynecol 153: 508–514, 1985
17. Packham DK, North RA, Fairley KF, Whitworth JA, Kincaid-Smith P: Membranous glomerulonephritis and pregnancy. Clin Nephrol 28: 56–64, 1987
18. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS: Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 39: 257–268, 2010
19. Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Garabet L, Salmon JE: Predictors of pregnancy outcomes in patients with lupus: A cohort study. Ann Intern Med 163: 153–163, 2015
20. Moroni G, Doria A, Giglio E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, de Liso F, Matinato C, Grossi C, Gatto M, Castellana P, Limardo M, Meroni PL, Messa P, Ravani P, Mosca M: Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. J Autoimmun 74: 6–12, 2016
21. Moroni G, Doria A, Giglio E, Imbasciati E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, Gatto M, de Liso F, Grossi C, Meroni PL, Cabiddu G, Messa P, Ravani P, Mosca M: Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. J Autoimmun 74: 194–200, 2016
22. Chakravarty EF, Colón I, Langen ES, Nix DA, El-Sayed YY, Genovese MC, Druzin ML: Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 192: 1897–1904, 2005
23. Carmona F, Font J, Moga I, Làzaro I, Cervera R, Pac V, Balasch J: Class III-IV proliferative lupus nephritis and pregnancy: A study of 42 cases. Am J Reprod Immunol 53: 182–188, 2005
24. Bramham K, Hunt BJ, Bewley S, Germain S, Calatayud I, Khamashta MA, Nelson-Piercy C: Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol 38: 1906–1913, 2011
25. Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E: The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 55: 2778–2784, 2010
26. Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A: EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 76: 476–485, 2017
27. Clowse ME, Magder L, Witter F, Petri M: Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54: 3640–3647, 2006
28. Kaplan YC, Ozsarfati J, Nickel C, Koren G: Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: A systematic review and meta-analysis. Br J Clin Pharmacol 81: 835–848, 2016
29. Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, Khamashta MA, Kim MY, Saxena A, Friedman D, Llanos C, Piette JC, Buyon JP: Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 126: 76–82, 2012
30. Fredi M, Lazzaroni MG, Tani C, Ramoni V, Gerosa M, Inverardi F, Sfriso P, Caramaschi P, Andreoli L, Sinico RA, Motta M, Lojacono A, Trespidi L, Strigini F, Brucato A, Caporali R, Doria A, Guillevin L, Meroni PL, Montecucco C, Mosca M, Tincani A: Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies. Autoimmun Rev 14: 686–691, 2015
31. Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N: Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 366: 2257–2266, 2012
32. Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, Lansang MC, Stevanovic R, Fisher ND, Hollenberg NK: Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy. Diabetes Care 28: 1988–1994, 2005
33. Ahmed SB, Kang AK, Burns KD, Kennedy CR, Lai V, Cattran DC, Scholey JW, Miller JA: Effects of oral contraceptive use on the renal and systemic vascular response to angiotensin II infusion. J Am Soc Nephrol 15: 780–786, 2004
34. Kang AK, Duncan JA, Cattran DC, Floras JS, Lai V, Scholey JW, Miller JA: Effect of oral contraceptives on the renin angiotensin system and renal function. Am J Physiol Regul Integr Comp Physiol 280: R807–R813, 2001
35. Bailie GR, Elder SJ, Mason NA, Asano Y, Cruz JM, Fukuhara S, Lopes AA, Mapes DL, Mendelssohn DC, Bommer J, Young EW: Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: Results from the DOPPS. Nephrol Dial Transplant 22: 1163–1170, 2007
36. Lim VS, Henriquez C, Sievertsen G, Frohman LA: Ovarian function in chronic renal failure: Evidence suggesting hypothalamic anovulation. Ann Intern Med 93: 21–27, 1980
37. Hou SH, Grossman S, Molitch ME: Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis. Am J Kidney Dis 6: 245–249, 1985
38. Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M: Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis 29: 685–690, 1997
39. Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC: Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med 119: 355. e25–355.e33, 2006
40. Boumpas DT, Austin HA III, Vaughan EM, Yarboro CH, Klippel JH, Balow JE: Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119: 366–369, 1993
41. Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, Al-Inany HG, Falcone T: Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: A systematic review and meta-analysis. Fertil Steril 95: 906–914, 2011
42. Del Mastro L, Ceppi M, Poggio F, Bighin C, Peccatori F, Demeestere I, Levaggi A, Giraudi S, Lambertini M, D’Alonzo A, Canavese G, Pronzato P, Bruzzi P: Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials. Cancer Treat Rev 40: 675–683, 2014
43. Elgindy E, Sibai H, Abdelghani A, Mostafa M: Protecting ovaries during chemotherapy through gonad suppression: A systematic review and meta-analysis. Obstet Gynecol 126: 187–195, 2015
44. Koh JH, Ko HS, Lee J, Jung SM, Kwok SK, Ju JH, Park SH: Pregnancy and patients with preexisting lupus nephritis: 15 Years of experience at a single center in Korea. Lupus 24: 764–772, 2015
45. Cabiddu G, Castellino S, Gernone G, Santoro D, Moroni G, Giannattasio M, Gregorini G, Giacchino F, Attini R, Loi V, Limardo M, Gammaro L, Todros T, Piccoli GB: A best practice position statement on pregnancy in chronic kidney disease: The Italian Study Group on Kidney and Pregnancy. J Nephrol 29: 277–303, 2016
46. Diav-Citrin O, Shechtman S, Halberstadt Y, Finkel-Pekarsky V, Wajnberg R, Arnon J, Di Gianantonio E, Clementi M, Ornoy A: Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reprod Toxicol 31: 540–545, 2011
47. Hod M, van Dijk DJ, Karp M, Weintraub N, Rabinerson D, Bar J, Peled Y, Erman A, Boner G, Ovadia J: Diabetic nephropathy and pregnancy: The effect of ACE inhibitors prior to pregnancy on fetomaternal outcome. Nephrol Dial Transplant 10: 2328–2333, 1995
48. Bar J, Chen R, Schoenfeld A, Orvieto R, Yahav J, Ben-Rafael Z, Hod M: Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy. J Pediatr Endocrinol Metab 12: 659–665, 1999
49. Nielsen LR, Damm P, Mathiesen ER: Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: Effect of intensified antihypertensive therapy? Diabetes Care 32: 38–44, 2009
50. Fraser FC, Sajoo A: Teratogenic potential of corticosteroids in humans. Teratology 51: 45–46, 1995
51. Hviid A, Molgaard-Nielsen D: Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ 183: 796–804, 2011
52. Murphy KE, Hannah ME, Willan AR, Hewson SA, Ohlsson A, Kelly EN, Matthews SG, Saigal S, Asztalos E, Ross S, Delisle MF, Amankwah K, Guselle P, Gafni A, Lee SK, Armson BA; MACS Collaborative Group: Multiple courses of antenatal corticosteroids for preterm birth (MACS): A randomized controlled trial. Lancet 372: 2143–2151, 2008
53. Lockwood CJ, Radunovic N, Nastic D, Petkovic S, Aigner S, Berkowitz GS: Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy. J Perinat Med 24: 243–251, 1996
54. Nørgård B, Pedersen L, Fonager K, Rasmussen SN, Sørensen HT: Azathioprine, mercaptopurine and birth outcome: A population-based cohort study. Aliment Pharmacol Ther 17: 827–834, 2003
55. Coscia LA, Constantinescu S, Moritz MJ, Frank AM, Ramirez CB, Maley WR, Doria C, McGrory CH, Armenti VT: Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. Clin Transpl 2010: 65–85, 2010
56. Bar Oz B, Hackman R, Einarson T, Koren G: Pregnancy outcome after cyclosporine therapy during pregnancy: A meta-analysis. Transplantation 71: 1051–1055, 2001
57. Kainz A, Harabacz I, Cowlrick IS, Gadgil SD, Hagiwara D: Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 70: 1718–1721, 2000
58. Kim H, Jeong JC, Yang J, Yang WS, Ahn C, Han DJ, Park JS, Park SK: The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation. Clin Transplant 29: 142–148, 2015
59. Zheng S, Easterling TR, Umans JG, Miodovnik M, Calamia JC, Thummel KE, Shen DD, Davis CL, Hebert MF: Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit 34: 660–670, 2012
60. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G: Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 152: 573–576, 1992
61. Østensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai R, Meroni P, Cetin I, Derksen R, Branch W, Motta M, Gordon C, Ruiz-Irastorza G, Spinillo A, Friedman D, Cimaz R, Czeizel A, Piette JC, Cervera R, Levy RA, Clementi M, De Carolis S, Petri M, Shoenfeld Y, Faden D, Valesini G, Tincani A: Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8: 209, 2006
62. Chakravarty EF, Murray ER, Kelman A, Farmer P: Pregnancy outcomes after maternal exposure to rituximab. Blood 117: 1499–1506, 2011
63. Hladunewich MA, Bramham K, Jim B, Maynard S: Managing glomerular disease in pregnancy. Nephrol Dial Transpant 32 [Suppl 1]: i48–i56, 2017
64. Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM: Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 372: 407–417, 2015
65. Magee LA; CHIPS Study Group, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquin JM: Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG 123: 1143–1151, 2016
66. Xie RH, Guo Y, Krewski D, Mattison D, Walker MC, Nerenberg K, Wen SW: Association between labetalol use for hypertension in pregnancy and adverse infant outcomes. Eur J Obstet Gynecol Reprod Biol 175: 124–128, 2014
67. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA: Major congenital malformations after first-trimester exposure to ACE inhibitors. NEngl J Med354: 2443–2451, 2006
68. Al-Rabadi L, Ayalon R, Bonegio RG, Ballard JE, Fujii AM, Henderson JM, Salant DJ, Beck LH Jr.: Pregnancy in a patient with primary membranous nephropathy and circulating anti-PLA2R antibodies: A case report. Am J Kidney Dis 67: 775–778, 2016
69. Kemper MJ, Wei C, Reiser J: Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (suPAR) from a mother to child. Am J Kidney Dis 61: 352, 2013
70. Piccoli GB, Daidola G, Attini R, Parisi S, Fassio F, Naretto C, Deagostini MC, Castelluccia N, Ferraresi M, Roccatello D, Todros T: Kidney biopsy in pregnancy: Evidence for counselling? A systematic narrative review. BJOG 120: 412–427, 2013
71. Hladunewich MA, Myers BD, Derby GC, Blouch KL, Druzin ML, Deen WM, Naimark DM, Lafayette RA: Course of preeclamptic glomerular injury after delivery. Am J Physiol Renal Physiol 294: F614–F620, 2008
72. Abbassi-Ghanavati M, Greer LG, Cunningham FG: Pregnancy and laboratory studies: A reference table for clinicians. Obstet Gynecol 114: 1326–1331, 2009
73. Sebestyen A, Varbiro S, Sara L, Deak G, Kerkovits L, Szabo I, Kiss I, Paulin F: Successful management of pregnancy with nephrotic syndrome due to preexisting membranous glomerulonephritis: A case report. Fetal Diagn Ther 24: 186–189, 2008
74. Ope-Adenuga S, Moretti M, Lakhi N: Management of membranous glomerulonephritis in pregnancy: A multidisciplinary challenge. Case Rep Obstet Gynecol 2015: 839376, 2015
75. Barbour SJ, Greenwald A, Djurdjev O, Levin A, Hladunewich MA, Nachman PH, Hogan SL, Cattran DC, Reich HN: Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int 81: 190–195, 2012
76. Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MS: Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med 370: 1307–1315, 2014
77. Zhang JJ, Ma XX, Hao L, Liu LJ, Lv JC, Zhang H: A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomesinpregnancy. ClinJ AmSocNephrol 10: 1964–1978, 2015
78. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y: Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-analysis. Obstet Gynecol 116: 402–414, 2010
79. Hofmeyr GJ, Atallah AN, Duley L: Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 3: CD001059, 2006
80. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649–658, 2003
81. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D’Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642–649, 2006
82. Bramham K, Seed PT, Lightstone L, Nelson-Piercy C, Gill C, Webster P, Poston L, Chappell LC: Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 89: 874–885, 2016
83. Piccoli GB, Gaglioti P, Attini R, Parisi S, Bossotti C, Olearo E, Oberto M, Ferraresi M, Rolfo A, Versino E, Biolcati M, Todros T: Pre-eclampsia or chronic kidney disease? The flow hypothesis. Nephrol Dial Transplant 28: 1199–1206, 2013
84. Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, Jank A, Kribs A, Cornely OA, Kreyssig C, Hemphill L, Rigby AC, Khedkar S, Lindner TH, Mallmann P, Stepan H, Karumanchi SA, Benzing T: Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124: 940–950, 2011
85. Constantinescu S, Pai A, Coscia LA, Davison JM, Moritz MJ, Armenti VT: Breast-feeding after transplantation. Best Pract Res Clin Obstet Gynaecol 28: 1163–1173, 2014
86. Nyberg G, Haljamäe U, Frisenette-Fich C, Wennergren M, Kjellmer I: Breast-feeding during treatment with cyclosporine. Transplantation 65: 253–255, 1998
87. Bramham K, Chusney G, Lee J, Lightstone L, Nelson-Piercy C: Breastfeeding and tacrolimus: Serial monitoring in breast-fed and bottle-fed infants. Clin J Am Soc Nephrol 8: 563–567, 2013
88. Beardmore KS, Morris JM, Gallery ED: Excretion of antihypertensive medication into human breast milk: A systematic review. Hypertens Pregnancy 21: 85–95, 2002
89. Begg EJ, Robson RA, Gardiner SJ, Hudson LJ, Reece PA, Olson SC, Posvar EL, Sedman AJ: Quinapril and its metabolite quinaprilat in human milk. Br J Clin Pharmacol 51: 478–481, 2001
90. Malik GH, Al-Mohaya S, Shaikh JF, Al-Wakeel J, Al-Hozaim W, Kechrid M, Al-Duhami H, Shetia MS, El Gamal H, Hammed D: Repeated pregnancies in patients with non-immunoglobulin a mesangioproliferative glomerulonephritis. Am J Nephrol 21: 378–382, 2001
91. Abe S: Pregnancy in glomerulonephritic patients with decreased renal function. Hypertens Pregnancy 15: 305–312, 1996
92. Packham DK, North RA, Fairley KF, Whitworth JA, Lloren PR, Lee E, Kincaid-Smith P: Pregnancy in women with diffuse mesangial proliferative glomerulonephritis. Clin Nephrol 29: 193–198, 1988
93. Hou SH, Grossman SD, Madias NE: Pregnancy in women with renal disease and moderate renal insufficiency. Am J Med 78: 185–194, 1985